Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial (Q43188314)
Jump to navigation
Jump to search
scientific article published on 20 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial |
scientific article published on 20 January 2010 |
Statements
1 reference
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial (English)
1 reference
J-U Blohmer
1 reference
P Schmid
1 reference
J Hilfrich
1 reference
K Friese
1 reference
A Kleine-Tebbe
1 reference
H Koelbl
1 reference
H Sommer
1 reference
G Morack
1 reference
M B Wischnewsky
1 reference
W Lichtenegger
1 reference
S Kuemmel
1 reference
20 January 2010
1 reference
1 reference
21
1 reference
7
1 reference
1430-1435
1 reference
Identifiers
1 reference
1 reference